KOSPIChemicals003240

Taekwang Industrial

₩888,000▼ 1.33%2026-10-02 close

Market Cap

₩989.8B

Turnover

₩1.4B

Volume

1,582 shares

Shares out.

1.1M

PER

8.5×

PBR

0.2×

EPS

₩106,610

Dividend Yield

0.19%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩1,750 per share · Prices as of the 2026-10-02 close

Report overview

Petrochemical Losses, Pivot to Materials and Consumer

The core petrochemical business has posted operating losses for four straight years, while specialty expansions in para-aramid and modacrylic plus the consolidation of Aekyung Industrial are reshaping the portfolio, all amid an ongoing dispute with the second-largest shareholder over treasury shares and payouts.

1
Consolidated revenue shrank from KRW 2.704tn in 2022 to KRW 1.827tn in 2025, with operating results in the red for four straight years: -KRW 122.1bn (2022), -KRW 99.4bn (2023), -KRW 27.2bn (2024) and -KRW 36.0bn (2025).
2
Quarterly operating losses narrowed from -KRW 41.9bn in 3Q25 to -KRW 1.1bn in 2Q26, while revenue rose to KRW 533.3bn in 1Q26 and KRW 557.7bn in 2Q26.
3
The Ulsan para-aramid line was expanded from 1,500 to 5,500 tonnes per year and started up in March 2026, while modacrylic capacity is being taken to 26,000 tonnes with KRW 150bn of capex targeting commercial output in June 2028.
4
The Aekyung Industrial control stake deal closed on 26 March 2026, and with Dongsung Pharm and a hotel asset added, the portfolio has widened into B2C and healthcare.
5
Governance friction persists as second-largest shareholder Truston Asset Management publicly objects to the value-up plan that keeps the 24.41% treasury stake for M&A currency rather than cancelling it.

Business structure

Founded in 1961, Taekwang Industrial is a combined petrochemical and fiber materials maker; according to the business mix compiled by WiseReport, petrochemicals such as PTA and AN account for 76% of revenue and fibers such as nylon and acrylic for 13%, alongside a leasing business and broadcasting/telecom operations run through subsidiaries.

The company has been steadily exiting low-margin commodity lines: it halted low-melting fiber output in July 2024, withdrew from the spandex business in China, and in April 2026 stopped acrylic production, once a mainstay product.

The focus has shifted to higher-value materials, as the Ulsan para-aramid plant was expanded from 1,500 to 5,500 tonnes per year, with 2026 output targeted at 2,600 tonnes to allow for quality testing and customer qualification.

In modacrylic, a premium wig fiber, it is the only domestic producer and ranks second globally by volume behind Japan's Kaneka, with 2026 output set to rise to 12,000 tonnes.

On 13 August 2026 it approved a KRW 150bn expansion toward 26,000 tonnes with commercial production targeted for June 2028, and management said it aims to lift its roughly 19% global modacrylic share to 33% by 2030.

In fine chemicals, sodium cyanide capacity is being doubled from 66,000 to 132,000 tonnes, while affiliate Daehan Synthetic Fiber has built commercial capability in liquid crystal polymer and plans to target industrial rope and composite markets in tandem with Taekwang's para-aramid.

On the new-business side, the purchase of about 63% of Aekyung Industrial (16,672,578 shares) closed on 26 March 2026, bringing it into the group, and with Dongsung Pharm (KRW 160bn) and hotel assets added, the footprint now spans cosmetics, bio and real estate.

Competitively, in para-aramid it is a late entrant chasing the number-two domestic position behind Kolon Industries (15,310 tonnes), while in commodity petrochemicals its smaller scale versus large naphtha crackers remains a structural constraint.

Earnings trend

Quarterly revenue · Operating profit

₩464.6B-₩18.9B25Q2₩445.2B-₩41.9B25Q3₩410.1B₩22.1B25Q4₩533.3B-₩11.4B26Q1₩557.7B-₩1.1B26Q2

RevenueOperating profit

Annual revenue · Operating profit

₩2.7T-₩122.1B2022₩2.3T-₩99.4B2023₩2.1T-₩27.2B2024₩1.8T-₩36B2025

RevenueOperating profit

Quarterly results · Last 5 quarters
Quarter	Revenue	Operating profit	Op. margin
2025Q2	₩464.6B	-₩18.9B	−4.1%
2025Q3	₩445.2B	-₩41.9B	−9.4%
2025Q4	₩410.1B	₩22.1B	5.4%
2026Q1	₩533.3B	-₩11.4B	−2.1%
2026Q2	₩557.7B	-₩1.1B	−0.2%

Annual results
Year	Revenue	Operating profit	Net income (parent)	Op. margin	ROE	Debt-to-equity
2022	₩2.7T	-₩122.1B	₩341.8B	−4.5%	8.3%	16.7%
2023	₩2.3T	-₩99.4B	-₩18.5B	−4.4%	−0.5%	17.6%
2024	₩2.1T	-₩27.2B	₩214.5B	−1.3%	5.5%	17.6%
2025	₩1.8T	-₩36B	₩80.8B	−2.0%	2.1%	13.5%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-09-04

Earnings analysis

Consolidated revenue declined for three consecutive years, from KRW 2.704tn in 2022 to KRW 2.265tn in 2023, KRW 2.122tn in 2024 and KRW 1.827tn in 2025.

Operating results stayed negative throughout: -KRW 122.1bn (2022), -KRW 99.4bn (2023), -KRW 27.2bn (2024) and -KRW 36.0bn (2025), with operating margins between -4.5% and -2.0%.

Net profit attributable to owners, by contrast, swung from -KRW 18.5bn in 2023 to KRW 214.5bn in 2024 and KRW 80.8bn in 2025, showing a recurring pattern in which non-operating items offset operating losses.

Quarterly, operating losses widened from -KRW 18.9bn in 2Q25 to -KRW 41.9bn in 3Q25, then turned to a KRW 22.1bn profit in 4Q25, before narrowing losses of -KRW 11.4bn in 1Q26 and just -KRW 1.1bn in 2Q26.

Revenue over the same span rose from KRW 410.1bn in 4Q25 to KRW 533.3bn in 1Q26 and KRW 557.7bn in 2Q26, largely reflecting the first full quarter of consolidation after the Aekyung Industrial acquisition closed on 26 March 2026.

For reference, Aekyung Industrial's own disclosure showed 2Q26 revenue of KRW 194.2bn, up 13.3% year on year and a quarterly record, first-half revenue of about KRW 353.0bn, and an overseas revenue share of 42% in 2Q.

Net profit to owners also recovered from -KRW 3.3bn in 3Q25 to KRW 35.2bn in 4Q25, KRW 28.3bn in 1Q26 and KRW 58.5bn in 2Q26; over the latest four quarters (3Q25-2Q26) it totalled KRW 118.7bn against a cumulative operating loss of KRW 32.3bn.

The balance sheet is conservative, with equity of KRW 3.964tn and total liabilities of KRW 534.0bn at end-2025 for a debt-to-equity ratio of 13.5%, but operating cash flow swung from +KRW 228.7bn in 2024 to -KRW 133.3bn in 2025, highlighting a gap between reported earnings and cash generation.

Industry analysis

For petrochemicals, oversupply left by China's massive capacity additions still anchors the cycle.

Korean fiber and petrochemical producers have faced the twin pressures of Chinese commodity oversupply and weak global demand, and TheBell reported in February 2026 that global chemical oversupply has driven four consecutive years of losses at Taekwang Industrial, with cheap Chinese commodity grades eroding both revenue and profitability.

WiseReport's company note similarly describes persistent difficulty in securing profitability due to Chinese capacity additions, weak demand and Middle East geopolitical risk, while noting that first-half 2026 results improved somewhat as revenue rose and operating losses narrowed.

Specialty products tell a different story. Para-aramid is used in ballistic protection and optical-cable reinforcement, and because customers require strict material certification, it is seen as a market where low-priced Chinese supply penetrates less easily.

Management cited restocking demand for body armour and rising optical-cable needs from AI infrastructure buildouts as reasons for the expansion.

Still, in the domestic field Kolon Industries leads with 15,310 tonnes and HS Hyosung Advanced Materials holds about 3,700 tonnes, so certification and pricing competition remain even after capacity is secured.

Consumer end-markets look comparatively supportive: Aekyung Industrial entered Poland and the UK with its Age 20's and Luna brands in 1Q26, securing access to Poland's largest drugstore network as it reduces reliance on China.

Outlook

Based on disclosed plans, the next one to two years hinge on specialty capacity ramp-ups and the earnings contribution from acquired companies. The expanded para-aramid line began operating in March 2026, and management intends to lift utilization step by step to reach full nameplate output in 2028.

Modacrylic capacity of 26,000 tonnes is being prepared with commercial production targeted for June 2028, while the sodium cyanide expansion targets completion in January 2027.

In consumer goods, Aekyung Industrial has reorganised its divisions into makeup, skincare, personal beauty and home care under a plan to lift cosmetics to more than 50% of sales by 2028. Not every expansion attempt has succeeded, however.

On 22 June 2026 Taekwang Industrial disclosed that the competitive bidding process for K Shipbuilding had been terminated after gaps with the seller's requests could not be bridged, and it says it will consider participating if a re-sale process begins.

On shareholder returns, the company replied that it would seek to raise the dividend per share for fiscal 2026, payable in 2027, above the prior year, that any treasury share cancellation would follow a holding-and-disposal plan submitted for approval at the 2027 annual general meeting, and that a stock split is under longer-term review.

In short, ramp-up utilization and consumer integration will drive the earnings line, while the treasury-share debate runs in parallel through the 2027 AGM.

Valuation

PER

8.5×

PBR

0.2×

ROE

2.9%

EPS

₩106,610

BPS

₩3,817,792

Dividend per share

₩1,750

This is a company read more through its balance sheet than its income statement. With four consecutive years of operating losses, earnings-based multiples swing with non-operating items, and the latest four quarters of net profit to owners were generated despite a cumulative operating loss.

The share price sits well below book value per share, and Truston Asset Management noted in July 2026 that the price-to-book ratio was less than half the peer-group average.

On dividends, Truston said in July 2026 that the 20-year average payout ratio was only 1% and demanded it be raised toward the listed-company average, so dividend-related metrics should be viewed as below market norms.

Narrowing the discount to net assets would require evidence of rising utilization at the new specialty lines, profit contribution from acquired businesses, and concrete treasury-share and dividend policies; conversely, prolonged core-business losses and governance conflict could keep the discount factors in place.

Either way, it makes sense to read the real-time multiples on screen alongside the direction of quarterly profits.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-09-04

Bull factors

Volume growth headroom from specialty expansions

Para-aramid capacity was raised from 1,500 to 5,500 tonnes a year with 2026 output targeted at 2,600 tonnes and full nameplate output planned by 2028 as utilization steps up. Modacrylic is also being expanded to 26,000 tonnes with KRW 150bn of capex, targeting commercial production in June 2028.

Both products still have utilization headroom, so filling the new capacity as planned would open a path to lower unit fixed costs and a better product mix. That outcome depends on the pace of certification and customer wins.

Revenue mix shift from consumer consolidation

Consolidated revenue of KRW 533.3bn in 1Q26 and KRW 557.7bn in 2Q26 compares with KRW 410.1bn in 4Q25. Aekyung Industrial posted record quarterly consolidated revenue of KRW 194.2bn in 2Q26, up 13.3% year on year, in its first full quarter inside the group.

Its overseas revenue share reached 42% in 2Q, seven percentage points higher than a year earlier. The structural point is the addition of a revenue stream with different cash-flow characteristics to a business previously dominated by cyclical petrochemicals.

Low leverage and a thick equity base

At end-2025, equity stood at KRW 3.964tn against total liabilities of KRW 534.0bn, a debt-to-equity ratio of just 13.5%, below 16.7% in 2022 and 17.6% in both 2023 and 2024.

Bloter reported in July 2026 that retained earnings amounted to KRW 4.217tn and the consolidated debt ratio was 12.9% at the end of the first quarter, close to a debt-free financial profile. That implies capacity to fund expansions and acquisitions without heavy reliance on external borrowing.

Bear factors

Structural losses in the core business

Operating results were negative for four straight years: -KRW 122.1bn (2022), -KRW 99.4bn (2023), -KRW 27.2bn (2024) and -KRW 36.0bn (2025), with a 2025 operating margin of -2.0%.

TheBell reported in February 2026 that a price war triggered by global oversupply is under way, expectations for a cyclical recovery are low, and cheap Chinese commodity products are eroding both revenue and margins.

Revenue is also shrinking as commodity lines are wound down, so it will take time for specialty volumes to offset the gap.

Conflict over treasury shares and payouts

The core of the value-up plan is to retain 271,769 treasury shares, equal to a 24.41% stake, as funding currency for M&A rather than cancelling them.

In a 30 June 2026 disclosure the company said it would draw up a treasury share holding and disposal plan for approval at the 2027 annual meeting, which Truston criticised as an after-the-fact excuse for avoiding cancellation.

The company had also previously pursued, then withdrew, a KRW 318.6bn exchangeable bond issue backed by the 24.4% treasury stake. Uncertainty persists until the policy takes final form.

Reliance on non-operating income and cash-flow gap

Net profit to owners was positive at KRW 214.5bn in 2024 and KRW 80.8bn in 2025, yet operating results in those years were -KRW 27.2bn and -KRW 36.0bn respectively. When much of the profit originates outside operations, year-to-year volatility tends to be high.

Operating cash flow also reversed from +KRW 228.7bn in 2024 to -KRW 133.3bn in 2025. Whether profit and cash generation improve together needs to be checked quarter by quarter.

Risk factors

Industry and cycle risk

Petrochemical spreads hinge on Chinese capacity additions and the direction of oil prices. WiseReport notes that oversupply from Chinese additions, weak demand and Middle East geopolitical risk continue to make profitability hard to secure, with sharp feedstock price spikes and supply-demand instability.

Rapid swings in raw material prices can move quarterly results materially through inventory valuation and lags in passing costs through. With commodity grades still a large share of the mix, that sensitivity is likely to persist.

Governance and regulatory risk

On 3 September 2026, Truston Asset Management sent an open letter to the board and all directors alleging interference by the group's management support council and demanded answers within 30 days.

If a substantive reply does not arrive within 30 days of receipt, it says it will consider inspecting accounting books, filing a shareholder derivative suit and requesting an extraordinary general meeting.

It also flagged that the company received six penalty points and a KRW 76m fine from the Korea Exchange over unfaithful disclosure. A prolonged dispute could absorb management resources and slow decision-making.

Integration and additional funding burden

Taekwang Industrial and its co-investors committed a total of KRW 160bn to acquire and stabilise Dongsung Pharm, and the Seoul Bankruptcy Court approved the completion of rehabilitation proceedings on 15 May 2026. However, Dongsung Pharm is still running operating losses, so it is early to call the turnaround complete.

TheBell noted that the key question is whether the rapidly expanded affiliate roster translates into actual earnings and cash flow, and that weak profitability at acquired firms could turn into a financial burden. Integrating several unrelated industries at once leaves room for unplanned costs.

What to watch next

Early October 2026
The 30-day deadline arrives for a reply to the open letter Truston sent on 3 September 2026. The board's response and any follow-up steps such as book inspection or an extraordinary meeting request will indicate how far the governance dispute escalates.
Mid-November 2026
Third-quarter 2026 results. It will be the second full quarter with Aekyung Industrial consolidated, so watch whether the narrowing to a KRW 1.1bn operating loss seen in 2Q26 continues and whether revenue holds around the mid-KRW 500bn range.
December 2026 to January 2027
Whether the sodium cyanide expansion from 66,000 to 132,000 tonnes, targeted for completion in January 2027, stays on schedule, and whether the 2,600-tonne para-aramid output target for 2026 is met, will show how well the specialty pivot is being executed.
January to February 2027
The fiscal 2026 year-end dividend decision. The company said it would seek to raise the dividend per share for fiscal 2026, payable in 2027, above the prior year, so the actual figure will show how concrete the payout policy has become.
March 2027 annual general meeting
The treasury share holding and disposal plan is due to be put to shareholders for approval. It will determine how the 24.41% treasury stake is cancelled or deployed, and whether it triggers a proxy contest with the second-largest shareholder.

Overall view

Taekwang Industrial is at a point where its legacy business and new ventures are moving in opposite directions.

Consolidated revenue fell from KRW 2.704tn in 2022 to KRW 1.827tn in 2025 with four consecutive years of operating losses, yet in 2026 quarterly revenue climbed above KRW 500bn and the operating loss narrowed to KRW 1.1bn in the second quarter.

Much of that shift stems from the Aekyung Industrial consolidation completed in March 2026 and the wind-down of commodity lines in favour of specialties, with the newly started para-aramid line and the 26,000-tonne modacrylic build targeted for June 2028 as the next tests.

The balance sheet is conservative, with a 13.5% debt-to-equity ratio at end-2025, but operating cash flow reversing from +KRW 228.7bn in 2024 to -KRW 133.3bn in 2025 highlights the gap between profit and cash.

On governance, the plan to retain the 24.41% treasury stake as M&A currency rather than cancel it and the second-largest shareholder's opposition remain live issues through the 2027 annual meeting.

The bull case rests on ramp-up utilization, consumer profit contribution and a thick equity base; the bear case rests on structural industry weakness, reliance on non-operating income and governance uncertainty. This report is for information purposes only and contains no buy or sell recommendation or target price.

Sources

Korea Exchange (KRX) — Prices · Market Cap · Volume
FSS electronic disclosure system (DART) — Financial statements · Dividend filings

Show 18 more articles and sources

Report written 2026-09-05 · Data as of 2026-09-04

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.